Oncolytics Biotech Inc. (TSX:ONC)

Oncolytics Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	143	103	132	131	96	131
Market Cap Growth	-	-22.52%	0.96%	36.08%	-26.39%	-19.30%
Enterprise Value	129	84	93	99	49	105
Last Close Price	1.42	1.33	1.79	2.22	1.75	3.02

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PB Ratio	23.40	17.13	4.80	4.95	2.67	5.29
P/TBV Ratio	23.40	17.13	4.80	4.95	2.67	5.29

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	0.15	0.18	0.02	0.01	0.02	0.02
Quick Ratio	2.24	2.39	8.24	8.15	15.37	11.56
Current Ratio	2.88	2.82	9.01	9.05	16.69	12.45
Return on Equity (ROE)	-249.28%	-189.05%	-102.66%	-79.34%	-86.45%	-182.63%
Return on Assets (ROA)	-74.56%	-74.11%	-55.46%	-40.44%	-40.88%	-58.93%
Return on Invested Capital (ROIC)	-146.95%	-124.82%	-76.99%	-52.89%	-52.97%	-124.54%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings Yield	-21.34%	-30.93%	-20.98%	-18.95%	-27.32%	-17.20%
FCF Yield	-17.32%	-26.54%	-21.51%	-17.86%	-23.59%	-16.89%
Buyback Yield / Dilution	-11.95%	-13.10%	-16.53%	-8.44%	-32.66%	-82.22%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2025

Data Sources Report a data error